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INTRODUCTION: For human body tissue regeneration, different approaches, including 
scaffold-based
[1]
, growth factor-based
[2]
 and cell-based tissue engineering
[3]
, are explored. In cell-
based tissue engineering, developing appropriate vehicles for cell encapsulation and delivery is 
highly important. The process of cell encapsulation must be cell-friendly for achieving high cell 
viability. Moreover, for microspherical delivery vehicles, the diameter of cell-encapsulated 
microspheres is a critical factor. The diameter should not be too small or too large. Degradation 
properties of polymers for microspheres are another important factor for cell delivery. Coaxial 
electrospray can produce core-shell structured microspheres and hence was investigated in this 
study for the encapsulation and delivery of cells. 
MATERIALS AND METHODS: To determine suitable electrospray parameters, solid, cell-free 
microspheres were made first by electrospray using polymer solutions of sodium alginate (SA), 
poly(vinyl alcohol), gelatin and mixed solutions (1:1) of two polymers. Then, cell-free 
microspheres with core-shell structure were produced by coaxial electrospray where a polymer 
solution was fed into outer tube and PBS was fed into inner tube of the coaxial nozzle. After 
process optimization, PBS was replaced by aqueous cell suspensions of human umbilical vein 
endothelial cells (HUVECs) in coaxial electrospray for making cell-encapsulated microspheres. 
The morphology and structure of cell-free and cell-containing microspheres were studied. The 
viability of HUVECs was studied using live and dead assay. Triggered cell release was also 
investigated. 
RESULTS AND DISCUSSION: Electrospray experiments showed that relatively large diameter 
(~5 micron) and uniform microspheres could be produced using mixed polymer solution of SA 
and gelatin. Therefore, coaxial cell electrospray was conducted using HUVEC cell suspensions 
and SA/gelatin polymer solution or SA solution alone, and a post-spray cross-linking treatment 
was added for the polymer shell. After further explorations, electrospray parameters (applied 
voltage, feeding rate ratio between the outer tube and inner tube, etc.) were fixed for fabricating 
cell-encapsulated microspheres. HUVECs with low cell density (5×106 cells/mL) and high cell 
density (1×107 cells/mL) were used for encapsulation. Fig.1 shows cell-encapsulated 
microspheres made by coaxial electrospray and post-spray crosslinking using different cell 
densities. Microspheres with regular spherical shape could be produced for both low cell density 
and high cell density. A higher cell loading efficiency was attained for microspheres using a 
higher cell density. Triggered cell release was achieved by treating cell-encapsulated 
microspheres with a 0.05M sodium citrate solution. The polymer shell of microspheres was 
dissolved gradually and after 10 minutes, polymer shell disappeared and cells were totally 
released (Fig.2). 
 
 
CONCLUSION: Coaxial electrospray proved to be a useful and adaptable technique for making 
cell delivery vehicles. With process optimization, sufficient cells could be encapsulated in core-
shell structured microspheres via coaxial electrospray. Cells contained in the core of 
microspheres were well protected and showed high viability after the electrospray process. 
Triggered release could be realized for delivering live cells, enabling cell-based therapies. 
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